136 related articles for article (PubMed ID: 30220975)
1. A high-throughput fluorescence polarization assay for discovering inhibitors targeting the DNA-binding domain of signal transducer and activator of transcription 3 (STAT3).
Shih PC; Yang Y; Parkinson GN; Wilderspin A; Wells G
Oncotarget; 2018 Aug; 9(66):32690-32701. PubMed ID: 30220975
[TBL] [Abstract][Full Text] [Related]
2. Optimization of a high-throughput fluorescence polarization assay for STAT5B DNA binding domain-targeting inhibitors.
Manaswiyoungkul P; Erdogan F; Olaoye OO; Cabral AD; de Araujo ED; Gunning PT
J Pharm Biomed Anal; 2020 May; 184():113182. PubMed ID: 32113119
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of quantitative assays for the identification of direct signal transducer and activator of transcription 3 (STAT3) inhibitors.
Furtek SL; Matheson CJ; Backos DS; Reigan P
Oncotarget; 2016 Nov; 7(47):77998-78008. PubMed ID: 27793003
[TBL] [Abstract][Full Text] [Related]
4. A high-throughput fluorescence polarization assay for signal transducer and activator of transcription 3.
Schust J; Berg T
Anal Biochem; 2004 Jul; 330(1):114-8. PubMed ID: 15183768
[TBL] [Abstract][Full Text] [Related]
5. Revisiting the development of small molecular inhibitors that directly target the signal transducer and activator of transcription 3 (STAT3) domains.
Shih PC
Life Sci; 2020 Feb; 242():117241. PubMed ID: 31891719
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel small molecules that inhibit STAT3-dependent transcription and function.
Kolosenko I; Yu Y; Busker S; Dyczynski M; Liu J; Haraldsson M; Palm Apergi C; Helleday T; Tamm KP; Page BDG; Grander D
PLoS One; 2017; 12(6):e0178844. PubMed ID: 28636670
[TBL] [Abstract][Full Text] [Related]
7. An HTS FP assay able to selectively identify STAT3-DBD inhibitors.
Meneghetti F; Barlocco D
Oncotarget; 2018 Oct; 9(77):34451-34452. PubMed ID: 30349637
[No Abstract] [Full Text] [Related]
8. Strategies and Approaches of Targeting STAT3 for Cancer Treatment.
Furtek SL; Backos DS; Matheson CJ; Reigan P
ACS Chem Biol; 2016 Feb; 11(2):308-18. PubMed ID: 26730496
[TBL] [Abstract][Full Text] [Related]
9. High-throughput thermofluor-based assays for inhibitor screening of STAT SH2 domains.
de Araujo ED; Manaswiyoungkul P; Israelian J; Park J; Yuen K; Farhangi S; Berger-Becvar A; Abu-Jazar L; Gunning PT
J Pharm Biomed Anal; 2017 Sep; 143():159-167. PubMed ID: 28600954
[TBL] [Abstract][Full Text] [Related]
10. Screening and biological evaluation of a novel STAT3 signaling pathway inhibitor against cancer.
Huang M; Chen Z; Zhang L; Huang Z; Chen Y; Xu J; Zhang J; Shu X
Bioorg Med Chem Lett; 2016 Nov; 26(21):5172-5176. PubMed ID: 27727126
[TBL] [Abstract][Full Text] [Related]
11. Novel STAT3 Inhibitors Targeting STAT3 Dimerization by Binding to the STAT3 SH2 Domain.
Hua Y; Yuan X; Shen YH; Wang J; Azeem W; Yang S; Gade A; Lellahi SM; Øyan AM; Ke X; Zhang WD; Kalland KH
Front Pharmacol; 2022; 13():836724. PubMed ID: 35712699
[TBL] [Abstract][Full Text] [Related]
12. A high-throughput assay for signal transducer and activator of transcription 5b based on fluorescence polarization.
Müller J; Schust J; Berg T
Anal Biochem; 2008 Apr; 375(2):249-54. PubMed ID: 18258175
[TBL] [Abstract][Full Text] [Related]
13. Structure-Activity Studies of Phosphopeptidomimetic Prodrugs Targeting the Src Homology 2 (SH2) Domain of Signal Transducer and Activator of Transcription 3 (Stat3).
Mandal PK; Ren Z; Chen X; Kaluarachchi K; Liao WS; McMurray JS
Int J Pept Res Ther; 2013 Mar; 19(1):3-12. PubMed ID: 24707243
[TBL] [Abstract][Full Text] [Related]
14. Small-molecule inhibitors targeting the DNA-binding domain of STAT3 suppress tumor growth, metastasis and STAT3 target gene expression in vivo.
Huang W; Dong Z; Chen Y; Wang F; Wang CJ; Peng H; He Y; Hangoc G; Pollok K; Sandusky G; Fu XY; Broxmeyer HE; Zhang ZY; Liu JY; Zhang JT
Oncogene; 2016 Feb; 35(6):783-92. PubMed ID: 26073084
[TBL] [Abstract][Full Text] [Related]
15. Identification of a New Series of STAT3 Inhibitors by Virtual Screening.
Matsuno K; Masuda Y; Uehara Y; Sato H; Muroya A; Takahashi O; Yokotagawa T; Furuya T; Okawara T; Otsuka M; Ogo N; Ashizawa T; Oshita C; Tai S; Ishii H; Akiyama Y; Asai A
ACS Med Chem Lett; 2010 Nov; 1(8):371-5. PubMed ID: 24900220
[TBL] [Abstract][Full Text] [Related]
16. MMPP Attenuates Non-Small Cell Lung Cancer Growth by Inhibiting the STAT3 DNA-Binding Activity
Son DJ; Zheng J; Jung YY; Hwang CJ; Lee HP; Woo JR; Baek SY; Ham YW; Kang MW; Shong M; Kweon GR; Song MJ; Jung JK; Han SB; Kim BY; Yoon DY; Choi BY; Hong JT
Theranostics; 2017; 7(18):4632-4642. PubMed ID: 29158850
[No Abstract] [Full Text] [Related]
17. Identification of STAT1 and STAT3 specific inhibitors using comparative virtual screening and docking validation.
Szelag M; Czerwoniec A; Wesoly J; Bluyssen HA
PLoS One; 2015; 10(2):e0116688. PubMed ID: 25710482
[TBL] [Abstract][Full Text] [Related]
18. Small-molecule compounds targeting the STAT3 DNA-binding domain suppress survival of cisplatin-resistant human ovarian cancer cells by inducing apoptosis.
Huang W; Liu Y; Wang J; Yuan X; Jin HW; Zhang LR; Zhang JT; Liu ZM; Cui JR
Eur J Med Chem; 2018 Sep; 157():887-897. PubMed ID: 30145375
[TBL] [Abstract][Full Text] [Related]
19. SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation.
Duan Z; Bradner JE; Greenberg E; Levine R; Foster R; Mahoney J; Seiden MV
Clin Cancer Res; 2006 Nov; 12(22):6844-52. PubMed ID: 17121906
[TBL] [Abstract][Full Text] [Related]
20. Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity.
Turkson J; Kim JS; Zhang S; Yuan J; Huang M; Glenn M; Haura E; Sebti S; Hamilton AD; Jove R
Mol Cancer Ther; 2004 Mar; 3(3):261-9. PubMed ID: 15026546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
